Sacheerome Limited, a company specializing in the creation and manufacturing of fragrances and flavors for the FMCG sector, is launching its IPO on June 9, 2025, with the subscription window closing on June 11, 2025. The Sacheerome IPO is a book-built issue with a total size of approximately ₹61.62 crores, consisting entirely of a fresh issue of 60.41 lakh equity shares. Sacheerome serves both food and non-food industries, supplying innovative solutions to major brands across India and international markets.
₹30
₹102
₹153
Expert Opinions
Market sentiment for Sacheerome IPO appears positive, driven by its presence in the fast-growing fragrances and flavors segment catering to FMCG giants in India and abroad. The company’s strengths include a diversified product portfolio, robust R&D capabilities, and a modern manufacturing facility with significant capacity, supporting innovation and scalability. However, risks include dependence on the cyclical FMCG sector, potential raw material price volatility, and competitive pressures from established global players.
For FY 2024, Sacheerome IPO reported a strong Return on Equity (ROE) of 29.60% and a Net Asset Value (NAV) of ₹37.95, signaling efficient capital utilization and healthy financials. From a long-term investment perspective, Sacheerome’s focus on product innovation and its established B2B relationships position it well for sustainable growth, though investors should monitor industry dynamics and execution risks closely.
Investor Considerations
Sacheerome IPO demonstrates strong fundamentals, with a robust presence in the B2B FMCG sector, supplying leading brands both domestically and internationally. The company’s FY 2024 financials are solid, reflected in a PAT margin of 14.86%, EBITDA margin of 21.62%, and Return on Net Worth (RoNW) of 25.78%, indicating efficient operations and profitability. The sector outlook is promising, as the global and Indian fragrances and flavors markets are projected for steady growth, driven by rising consumer demand and preference for natural products.
Sacheerome’s expansion plans, including new manufacturing units and R&D investments, support its growth prospects, especially in emerging markets like the Middle East. However, risks include raw material price volatility, competitive pressures, and exposure to FMCG sector cycles. For investors, the Sacheerome IPO may appeal to both short-term and long-term goals, but those with a long-term horizon could benefit more from the company’s innovation-driven growth trajectory.
| Date | GMP | Trend |
|---|---|---|
| 15 Jun 2025 11.59 | ₹30 | --- |
| 14 Jun 2025 10.51 | ₹30 | --- |
| 13 Jun 2025 13.02 | ₹30 | Down |
| 12 Jun 2025 10.42 | ₹40 | --- |
| 11 Jun 2025 20.20 | ₹40 | Up |
| 10 Jun 2025 15.46 | ₹35 | Up |
| 09 Jun 2025 11.08 | ₹30 | --- |
| 08 Jun 2025 11.45 | ₹30 | --- |
| 07 Jun 2025 10.38 | ₹30 | Up |
| 05 Jun 2025 11.10 | ₹25 | --- |
| 04 Jun 2025 15.52 | ₹25 | Up |
| 03 Jun 2025 16.03 | ₹21 | --- |
FAQs
The Grey Market Premium showed limited accuracy in predicting Sacheerome IPO’s listing performance. While the GMP of ₹30 predicted a significant premium of 29.41% over the issue price, the stock delivered an even stronger gain of 50%. With a prediction error of 15.91%, the GMP correctly predicted the positive listing direction but significantly underestimated the magnitude of gains, demonstrating its limitations as a precise price predictor in this case.
Sacheerome IPO Current GMP is ₹30.
Sacheerome IPO Expected Returns is 29.41%.
Sacheerome IPO estimated listing price is ₹132.